{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:49:30Z","timestamp":1775713770225,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-020-0305-8","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T10:05:06Z","timestamp":1595498706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Outcome measures based on digital health technology sensor data: data- and patient-centric approaches"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2480-3137","authenticated-orcid":false,"given":"Kirsten I.","family":"Taylor","sequence":"first","affiliation":[]},{"given":"Hannah","family":"Staunton","sequence":"additional","affiliation":[]},{"given":"Florian","family":"Lipsmeier","sequence":"additional","affiliation":[]},{"given":"David","family":"Nobbs","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Lindemann","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"305_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1394-3","volume":"19","author":"BR Bloem","year":"2019","unstructured":"Bloem, B. R. et al. The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson\u2019s disease. BMC Neurol. 19, 160 (2019).","journal-title":"BMC Neurol."},{"key":"305_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.11","volume":"3","author":"BM Bot","year":"2016","unstructured":"Bot, B. M. et al. The mPower study, Parkinson disease mobile data collected using ResearchKit. Sci. Data 3, 160011 (2016).","journal-title":"Sci. Data"},{"key":"305_CR3","doi-asserted-by":"publisher","DOI":"10.2196\/resprot.5990","volume":"5","author":"AL Silva de Lima","year":"2016","unstructured":"Silva de Lima, A. L. et al. Large-scale wearable sensor deployment in Parkinson\u2019s patients: The Parkinson@Home Study Protocol. JMIR Res. Protoc. 5, e172 (2016).","journal-title":"JMIR Res. Protoc."},{"key":"305_CR4","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/acn3.50853","volume":"6","author":"C Lo","year":"2019","unstructured":"Lo, C. et al. Predicting motor, cognitive & functional impairment in Parkinson\u2019s. Ann. Clin. Transl. Neurol. 6, 1498\u20131509 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"305_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/jamaneurol.2018.0809","volume":"75","author":"A Zhan","year":"2018","unstructured":"Zhan, A. et al. Using smartphones and machine learning to quantify Parkinson disease severity: the mobile Parkinson disease score. JAMA Neurol. 75, 876\u2013880 (2018).","journal-title":"JAMA Neurol."},{"key":"305_CR6","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mds.26642","volume":"31","author":"AJ Espay","year":"2016","unstructured":"Espay, A. J. et al. Technology in Parkinson\u2019s disease: challenges and opportunities: technology in PD. Mov. Disord. 31, 1272\u20131282 (2016).","journal-title":"Mov. Disord."},{"key":"305_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fnins.2018.00202","volume":"12","author":"JJ FitzGerald","year":"2018","unstructured":"FitzGerald, J. J., Lu, Z., Jareonsettasin, P. & Antoniades, C. A. Quantifying motor impairment in movement disorders. Front. Neurosci. 12, 202 (2018).","journal-title":"Front. Neurosci."},{"key":"305_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1088\/0143-0807\/31\/3\/003","volume":"31","author":"U Hassan","year":"2010","unstructured":"Hassan, U. & Anwar, M. S. Reducing noise by repetition: introduction to signal averaging. Eur. J. Phys. 31, 453\u2013465 (2010).","journal-title":"Eur. J. Phys."},{"key":"305_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138095","volume":"10","author":"HH Dodge","year":"2015","unstructured":"Dodge, H. H. et al. Use of high-frequency in-home monitoring data may reduce sample sizes needed in clinical trials. PLoS ONE 10, e0138095 (2015).","journal-title":"PLoS ONE"},{"key":"305_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00415-012-6624-1","volume":"260","author":"P Martinez-Martin","year":"2013","unstructured":"Martinez-Martin, P. et al. Expanded and independent validation of the Movement Disorder Society\u2013Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS). J. Neurol. 260, 228\u2013236 (2013).","journal-title":"J. Neurol."},{"key":"305_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/mds.27671","volume":"34","author":"AJ Espay","year":"2019","unstructured":"Espay, A. J. et al. A roadmap for implementation of patient-centered digital outcome measures in Parkinson\u2019s disease obtained using mobile health technologies. Mov. Disord. 34, 657\u2013663 (2019).","journal-title":"Mov. Disord."},{"key":"305_CR12","unstructured":"European Medicines Agency. Qualification opinion on stride velocity 95th centile as a secondary endpoint in Duchenne Muscular Dystrophy measured by a valid and suitable wearable device. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/qualification-opinion-stride-velocity-95th-centile-secondary-endpoint-duchenne-muscular-dystrophy_en.pdf (2019)."},{"key":"305_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27376","author":"F Lipsmeier","year":"2018","unstructured":"Lipsmeier, F. et al. Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson\u2019s disease clinical trial: Remote PD Testing with Smartphones. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.27376 (2018).","journal-title":"Mov. Disord."},{"key":"305_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/cpt.966","volume":"104","author":"ES Izmailova","year":"2018","unstructured":"Izmailova, E. S., Wagner, J. A. & Perakslis, E. D. Wearable devices in clinical trials: hype and hypothesis. Clin. Pharmacol. Ther. 104, 42\u201352 (2018).","journal-title":"Clin. Pharmacol. Ther."},{"key":"305_CR15","doi-asserted-by":"publisher","unstructured":"Coran, P. et al. Advancing the use of mobile technologies in clinical trials: recommendations from the clinical trials transformation initiative. Digit. Biomark. 145\u2013154, https:\/\/doi.org\/10.1159\/000503957 (2019).","DOI":"10.1159\/000503957"},{"key":"305_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000500413","volume":"3","author":"A Coravos","year":"2019","unstructured":"Coravos, A. et al. Digital medicine: a primer on measurement. Digit. Biomark. 3, 31\u201371 (2019).","journal-title":"Digit. Biomark."},{"key":"305_CR17","unstructured":"Food and Drug Administration. Patient-Focused Drug Development: Methods to Identify What Is Important to Patients Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders (U.S. Department of Health and Human Services, 2019)."},{"key":"305_CR18","unstructured":"Taylor, K. et al. A comprehensive digital biomarker active testing and passive monitoring suite for the remote and frequent assessment of motor symptom progression in Parkinson\u2019s disease [abstract]. Mov. Disord. 33 (2018)."},{"key":"305_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.parkreldis.2015.02.026","volume":"21","author":"S Arora","year":"2015","unstructured":"Arora, S. et al. Detecting and monitoring the symptoms of Parkinson\u2019s disease using smartphones: a pilot study. Parkinsonism Relat. Disord. 21, 650\u2013653 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"305_CR20","doi-asserted-by":"publisher","first-page":"e1528","DOI":"10.1212\/WNL.0000000000006366","volume":"91","author":"S Arora","year":"2018","unstructured":"Arora, S. et al. Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD. Neurology 91, e1528\u2013e1538 (2018).","journal-title":"Neurology"},{"key":"305_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.smrv.2010.10.001","volume":"15","author":"A Sadeh","year":"2011","unstructured":"Sadeh, A. The role and validity of actigraphy in sleep medicine: an update. Sleep. Med. Rev. 15, 259\u2013267 (2011).","journal-title":"Sleep. Med. Rev."},{"key":"305_CR22","first-page":"195","volume":"4","author":"D Castaneda","year":"2018","unstructured":"Castaneda, D., Esparza, A., Ghamari, M., Soltanpur, C. & Nazeran, H. A review on wearable photoplethysmography sensors and their potential future applications in health care. Int. J. Biosens. Bioelectron. 4, 195\u2013202 (2018).","journal-title":"Int. J. Biosens. Bioelectron."},{"key":"305_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00702-019-02017-9","volume":"126","author":"I Teshuva","year":"2019","unstructured":"Teshuva, I. et al. Using wearables to assess bradykinesia and rigidity in patients with Parkinson\u2019s disease: a focused, narrative review of the literature. J. Neural Transm. (Vienna) 126, 699\u2013710 (2019).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"305_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/NRE-151236","volume":"37","author":"M Mancini","year":"2015","unstructured":"Mancini, M. et al. Continuous monitoring of turning in Parkinson\u2019s disease: rehabilitation potential. NeuroRehabilitation 37, 3\u201310 (2015).","journal-title":"NeuroRehabilitation"},{"key":"305_CR25","doi-asserted-by":"publisher","unstructured":"Cheng, W.-Y. et al. Smartphone-based continuous mobility monitoring of Parkinsons disease patients reveals impacts of ambulatory bout length on gait features. In 2017 IEEE Life Sciences Conference (LSC), Sydney, NSW pp. 166\u2013169 (IEEE, 2017). https:\/\/doi.org\/10.1109\/LSC.2017.8268169.","DOI":"10.1109\/LSC.2017.8268169"},{"key":"305_CR26","unstructured":"Yang, J. & Honavar, V. In: Liu, H., Motoda, H. (eds) Feature Extraction, Construction and Selection 453 (Springer, 1998)."},{"key":"305_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1214\/09-SS054","volume":"4","author":"S Arlot","year":"2010","unstructured":"Arlot, S. & Celisse, A. A survey of cross-validation procedures for model selection. Stat. Surv. 4, 40\u201379 (2010).","journal-title":"Stat. Surv."},{"key":"305_CR28","unstructured":"Food and Drug Administration. The Voice of the Patient: Parkinson\u2019s Disease (2016)."},{"key":"305_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/ageing\/afl105","volume":"35","author":"N Miller","year":"2006","unstructured":"Miller, N., Noble, E., Jones, D. & Burn, D. Hard to swallow: dysphagia in Parkinson\u2019s disease. Age Ageing 35, 614\u2013618 (2006).","journal-title":"Age Ageing"},{"key":"305_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41687-017-0013-6","volume":"1","author":"L Humphrey","year":"2017","unstructured":"Humphrey, L. et al. A comparison of three methods to generate a conceptual understanding of a disease based on the patients\u2019 perspective. J. Patient Rep. Outcomes 1, 9 (2017).","journal-title":"J. Patient Rep. Outcomes"},{"key":"305_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jval.2017.09.012","volume":"21","author":"B Byrom","year":"2018","unstructured":"Byrom, B. et al. Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO consortium. Value Health 21, 631\u2013639 (2018).","journal-title":"Value Health"},{"key":"305_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun, V. & Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 3, 77\u2013101 (2006).","journal-title":"Qual. Res. Psychol."},{"key":"305_CR33","unstructured":"Kelle, U. \u201cEmergence\u201d vs. \u201cForcing\u201d of Empirical Data? A Crucial Problem of \u201cGrounded Theory\u201d Reconsidered. Historical Social Research\/Historische Sozialforschung Supplement 19, 133\u2013156 (2007)."},{"key":"305_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jad.2019.04.087","volume":"253","author":"Y Tazawa","year":"2019","unstructured":"Tazawa, Y. et al. Actigraphy for evaluation of mood disorders: a systematic review and meta-analysis. J. Affect. Disord. 253, 257\u2013269 (2019).","journal-title":"J. Affect. Disord."},{"key":"305_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.21037\/atm.2019.06.79","volume":"7","author":"JM Raja","year":"2019","unstructured":"Raja, J. M. et al. Apple watch, wearables, and heart rhythm: where do we stand? Ann. Transl. Med. 7, 417 (2019).","journal-title":"Ann. Transl. Med."},{"key":"305_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ahj.2018.09.002","volume":"207","author":"MP Turakhia","year":"2019","unstructured":"Turakhia, M. P. et al. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. Am. Heart J. 207, 66\u201375 (2019).","journal-title":"Am. Heart J."},{"key":"305_CR37","first-page":"98","volume":"245","author":"T Hao","year":"2017","unstructured":"Hao, T., Chang, H., Ball, M., Lin, K. & Zhu, X. cHRV uncovering daily stress dynamics using bio-signal from consumer wearables. Stud. Health Technol. Inform. 245, 98\u2013102 (2017).","journal-title":"Stud. Health Technol. Inform."},{"key":"305_CR38","unstructured":"Food and Drug Administration. Guidances with Digital Health Content (2019)."},{"key":"305_CR39","unstructured":"National Institute for Health and Care Excellence. Evidence Standards Framework For Digital Health Technologies (2019)."},{"key":"305_CR40","unstructured":"Dashiell-Aje, E., Kovacs, S. & Sacks, L. Regulatory perspective: digital health technology tools. Use in clinical investigations to evaluate clinical benefit in patients. https:\/\/globalforum.diaglobal.org\/issue\/june-2019\/regulatory-perspective-digital-health-technology-tools\/ (2019)."},{"key":"305_CR41","unstructured":"Food and Drug Administration. Patient-Focused Drug Development Guidance Public Workshop: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making, Silver Spring, MD, 6 December (FDA, 2019). https:\/\/globalforum.diaglobal.org\/issue\/june-2019\/regulatory-perspective-digital-health-technology-tools\/."},{"key":"305_CR42","unstructured":"European Medicines Agency. Questions and answers: Qualification of digital technology-based methodologies to support approval of medicinal products. https:\/\/www.ema.europa.eu\/en\/documents\/other\/questions-answers-qualification-digital-technology-based-methodologies-support-approval-medicinal_en.pdf (2020)."},{"key":"305_CR43","doi-asserted-by":"publisher","first-page":"105962","DOI":"10.1016\/j.cct.2020.105962","volume":"91","author":"MK Walton","year":"2020","unstructured":"Walton, M. K. et al. Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials. Contemp. Clin. Trials 91, 105962 (2020).","journal-title":"Contemp. Clin. Trials"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-020-0305-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-020-0305-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-020-0305-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T18:25:34Z","timestamp":1696443934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-020-0305-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1038\/s41746-020-0305-8","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"20 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.I.T., H.S., F.L., and D.N. are full-time employees of F. Hoffmann-La Roche Ltd. K.I.T. and H.S. are shareholders of F. Hoffmann-La Roche Ltd. M.L. is a consultant to F. Hoffmann-La Roche Ltd through Inovigate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}